Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
Simulations Plus, Inc., a provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has received a Phase II SBIR NIH grant for the further development and validation of its novel BIOLOGXsym™ platform.
